Vizient has ranked Rush University Medical Center #1 for quality among the nation’s most prestigious academic medical centers. Learn more.

Excellence is just the beginning.


French German Italian Portuguese Russian

Non-Hodgkin Lymphoma

Treatment Study for Patients with Diffuse Large B-Cell Lymphoma After aHCT

Effect of blinatumomab on minimal residual disease in subjects with diffuse large B-cell lymphoma post-autologous hematopoietic stem-cell transplantation.

Treatment Study for Patients with Marginal Zone Lymphoma

Study of acalabrutinib alone or in combination with rituximab in indolent B-cell non-Hodgkin lymphoma.

Treatment Study for Patients with Relapsed or Refractory Non-Hodgkin’s B-cell Lymphoma

Multiple dose regimens of MT-3724 with lenalidomide for the treatment of patients with relapsed/refractory diffuse large B-cell (DLBCL) non-Hodgkin’s lymphoma.